In millions, except per share items | Dec-31-13 | Sep-30-13 | Jun-30-13 | Mar-31-13 | Dec-31-12 | Sep-30-12 | Jun-30-12 | Mar-31-12 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Interest income: |
Interest income on loans | 5.5 | 5.2 | 4.8 | 4.7 | 4.8 | 4.9 | 4.9 | 5.0 |
Interest income on investments | 2.5 | 2.5 | 2.8 | | 3.1 | 3.2 | 3.5 | |
| 5.5 | 5.2 | 4.9 | 8.3 | 4.9 | 5.0 | 5.0 | 9.9 |
Interest on deposits | 1.9 | 2.0 | 2.0 | 2.0 | 2.3 | 2.5 | 2.7 | 2.9 |
Total interest expense | 1.9 | 2.0 | 2.0 | 2.0 | 2.3 | 2.5 | 2.7 | 2.9 |
Net interest income | 7.4 | 7.2 | 6.9 | 10.3 | 7.2 | 7.5 | 7.7 | 12.9 |
Provision for loan losses | 0.1 | 0.4 | 0.2 | 0.0 | 0.5 | 0.2 | 0.1 | 0.1 |
Net interest income after provision for loan losses | 7.3 | 6.8 | 6.7 | 10.3 | 6.7 | 7.3 | 7.6 | 12.8 |
Deposit and loan fees | 0.1 | 0.1 | 0.1 | | 0.1 | 0.1 | 0.1 | |
Gain on sale of investments, net | | | 0.6 | | | 0.6 | | |
Other non-interest income | 0.2 | 0.3 | 0.3 | 0.6 | 0.2 | 0.6 | 0.3 | 0.2 |
Total non-interest income | 0.3 | 0.3 | 0.9 | 0.6 | 0.3 | 1.3 | 0.4 | 0.2 |
Non-interest expenses | 3.6 | 3.6 | 3.7 | 3.7 | 3.4 | 3.4 | 3.4 | 3.4 |
Pre-tax income before non-recurring items | 2.7 | 2.2 | 2.7 | 2.4 | 2.2 | 2.8 | 2.8 | 2.9 |
Non-recurring items | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 |
Pre-tax income | 2.7 | 2.1 | 2.7 | 2.3 | 2.2 | 2.7 | 2.8 | 2.9 |
Income taxes | 0.9 | 0.7 | 1.0 | 0.8 | 0.7 | 1.0 | 1.0 | 0.9 |
Tax rate | 34.1% | 34.3% | 35.3% | 34.5% | 31.2% | 35.2% | 35.1% | 32.7% |
Net income | 1.8 | 1.4 | 1.7 | 1.5 | 1.5 | 1.7 | 1.8 | 1.9 |
Net margin | 23.0% | 19.6% | 23.0% | 14.1% | 21.7% | 20.5% | 22.8% | 14.9% |
|
Basic EPS | $0.07 | $0.05 | $0.07 | $0.06 | $0.06 | $0.07 | $0.07 | $0.08 |
Diluted EPS | $0.07 | $0.05 | $0.07 | $0.06 | $0.06 | $0.07 | $0.07 | $0.08 |
|
Shares outstanding (basic) | 25.9 | 25.8 | 25.8 | 25.7 | 25.7 | 25.7 | 25.7 | 25.6 |
Shares outstanding (diluted) | 26.2 | 26.1 | 26.1 | 25.8 | 25.8 | 25.7 | 25.7 | 25.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |